Organization
NIH
Type
NIH
Link
Number
PAR-25-175
Comments
LOI due 30 days prior to the application due date
Brief Description
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites R01 grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of these modalities in the characterization of therapy response and/or emergence of treatment resistance.